Neoplasia (United States)
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 4.8 | Q2 | 72.7% | 2.284 | Q1 | 96.3% |
| 2024 | 7.7 | Q1 | 87.7% | 2.167 | Q1 | 96.0% |
| 2023 | 6.3 | Q1 | 82.5% | 1.887 | Q1 | 95.1% |
| 2022 | 4.8 | Q2 | 69.7% | 1.451 | Q2 | 92.6% |
| 2021 | 6.2 | Q2 | 76.1% | 1.424 | Q1 | 92.5% |
| 2020 | — | — | 2.520 | Q1 | 97.0% | |
| 2019 | — | — | 2.414 | Q1 | 96.8% | |
| 2018 | — | — | 1.987 | Q1 | 95.0% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1522-8002
ISSN
1476-5586
region
Northern America
coverage
1999-2026